Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,726 public trials 585 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Active, Not Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis

NCT03731260

Conditions
Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients

NCT05741944

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +3 more
Locations
  • Radboud UMC Nijmegen, Gelderland, Netherlands
  • Maastricht UMC Maastricht, Limburg, Netherlands
  • Netherlands Cancer Institue Amsterdam, North Holland, Netherlands
  • UMC Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details
Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details

Related conditions